Testosterone MDL Judge: Reference Listed Drug Claims Are Preempted

(November 11, 2015, 10:56 AM EST) -- CHICAGO — Although two generic testosterone replacement therapy products are reference listed drugs (RLDs), their manufacturers still cannot add new warnings and claims by plaintiffs in a multidistrict litigation are preempted...
To view the full article, register now.